Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson’s disease

Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson’s disease

<p>Abstract</p> <p>Background</p> <p>Retinoic acid (RA) is a biologically active derivative of vitamin A. Previous studies have demonstrated that RA has protective effects against damage caused by H<sub>2</sub>O<sub>2</sub> or oxygen-glucose depr...

Full description

Bibliographic Details
Main Authors:	Yin Lian-Hu, Shen Hui, Diaz-Ruiz Oscar, Bäckman Cristina M, Bae Eunkyung, Yu Seong-Jin, Wang Yun
Format:	Article
Language:	English
Published:	BMC 2012-10-01
Series:	BMC Neuroscience
Online Access:	http://www.biomedcentral.com/1471-2202/13/120

Similar Items

Mechanisms of Dopaminergic Neurodegeneration in Parkinson's Disease
by: Verma, Aditi
Published: (2018)

9-cis retinoic acid induces neurorepair in stroke brain
by: Seong-Jin Yu, et al.
Published: (2017-07-01)

The effects of 9-cis retinoic acid on mitochondrial biogenesis
by: Mary Hsiao-Mei, Wu, et al.
Published: (2004)

LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease
by: Chen Yao, et al.
Published: (2010-10-01)

Intestinal absorption and metabolism of 9-cis-beta-carotene in vivo: biosynthesis of 9-cis-retinoic acid.
by: X. Hébuterne, et al.
Published: (1995-06-01)

Phenothiazines interfere with dopaminergic neurodegeneration in Caenorhabditis elegans models of Parkinson's disease
by: Justyna B. Mocko, et al.
Published: (2010-10-01)

Stimulation of Phospholipid Scrambling of the Erythrocyte Membrane by 9-Cis-Retinoic Acid
by: Majed Abed, et al.
Published: (2017-01-01)

Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration
by: Dong-Young Choi, et al.
Published: (2013-01-01)

Vulnerability of mesostriatal dopaminergic neurons in Parkinson’s disease
by: Tomás González-Hernández, et al.
Published: (2010-10-01)

Elucidating the Cellular and Molecular Changes of Dopaminergic Neurons by Rotenone-Induced Neurodegeneration in Zebrafish
by: Ngo, Dung
Published: (2018)

Roles of FGF20 in dopaminergic neurons and Parkinson’s disease
by: Nobuyuki eItoh, et al.
Published: (2013-05-01)

Microsomal prostaglandin E synthase-1 is a critical factor in dopaminergic neurodegeneration in Parkinson's disease
by: Yuri Ikeda-Matsuo, et al.
Published: (2019-04-01)

Interleukin-4 Protects Dopaminergic Neurons In vitro but Is Dispensable for MPTP-Induced Neurodegeneration In vivo
by: Laura Hühner, et al.
Published: (2017-03-01)

Dual effects of 9-cis retinoic acid on ACTH-dependent hyperplastic adrenal tissues
by: Francesca Pecori Giraldi, et al.
Published: (2021-07-01)

α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9)
by: Guillaume Daniel, et al.
Published: (2015-01-01)

Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
by: Siyan Zhang, et al.
Published: (2020-08-01)

Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration
by: Elpida Tsika, et al.
Published: (2014-11-01)

Molecular Regulation in Dopaminergic Neuron Development. Cues to Unveil Molecular Pathogenesis and Pharmacological Targets of Neurodegeneration
by: Floriana Volpicelli, et al.
Published: (2020-06-01)

Moxibustion Protects Dopaminergic Neurons in Parkinson’s Disease through Antiferroptosis
by: Zifeng Huang, et al.
Published: (2021-01-01)

Induced dopaminergic neurons: A new promise for Parkinson’s disease
by: Zhimin Xu, et al.
Published: (2017-04-01)

Dopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesis.
by: Alisdair McNeill, et al.
Published: (2013-01-01)

Degeneration of dopaminergic neurons due to metabolic alterations and Parkinson’s disease
by: Juhyun eSong, et al.
Published: (2016-03-01)

Reconstruction of Dopaminergic neurons Metabolic Network with Application to Parkinson's Disease
by: Chao-Min Wang, et al.
Published: (2015)

The role of polyunsaturated fatty acids and 9-cis retinoic acid in PPAR-mediated cholesterol efflux
by: Hsia-Yuan Ying, et al.
Published: (2006)

Glut9-mediated Urate Uptake Is Responsible for Its Protective Effects on Dopaminergic Neurons in Parkinson’s Disease Models
by: Mingxia Bi, et al.
Published: (2018-01-01)

PET analysis of dopaminergic neurodegeneration in relation to immobility in the MPTP-treated common marmoset, a model for Parkinson's disease.
by: Kiyoshi Ando, et al.
Published: (2012-01-01)

Peripheral Inflammation Increases the Damage in Animal Models of Nigrostriatal Dopaminergic Neurodegeneration: Possible Implication in Parkinson's Disease Incidence
by: A. Machado, et al.
Published: (2011-01-01)

Tetraspanin (TSP-17) protects dopaminergic neurons against 6-OHDA-induced neurodegeneration in C. elegans.
by: Neda Masoudi, et al.
Published: (2014-12-01)

Post-surgical treatment of thyroid carcinoma in dogs with retinoic acid 9 cis improves patient outcome
by: V. Castillo, et al.
Published: (2016-01-01)

Long-Term Health of Dopaminergic Neuron Transplants in Parkinson's Disease Patients
by: Penelope J. Hallett, et al.
Published: (2014-06-01)

Adult generation of dopaminergic neurons in a genetic model of Parkinson's disease
by: Brown, Sarah
Published: (2018)

Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans
by: Se-Myeong Cheon, et al.
Published: (2017-01-01)

Exposure to mitochondrial genotoxins and dopaminergic neurodegeneration in Caenorhabditis elegans.
by: Claudia P González-Hunt, et al.
Published: (2014-01-01)

Dopaminergic agonists in Parkinson's disease
by: A. Alonso Cánovas, et al.
Published: (2014-05-01)

Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson′s disease?
by: Björn Spittau
Published: (2015-01-01)

Neuroprotective Effects of Thymol, a Dietary Monoterpene Against Dopaminergic Neurodegeneration in Rotenone-Induced Rat Model of Parkinson’s Disease
by: Hayate Javed, et al.
Published: (2019-03-01)

The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease
by: Briana R. De Miranda, et al.
Published: (2021-06-01)

Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease
by: Richard Gordon, et al.
Published: (2016-09-01)

Pharmacogentic factors influencing the metabolism of 13-cis retinoic acid
by: Rowbotham, Sophie E.
Published: (2008)

13-cis-retinoic acid is an endogenous compound in human serum.
by: GW Tang, et al.
Published: (1990-02-01)